http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#head http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#assertion http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#assertion http://bio2rdf.org/drugbank:DB00541 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB00872 http://bio2rdf.org/drugbank:DB00872 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB00872 http://bio2rdf.org/drugbank_resource:DB00541_DB00872 http://purl.org/dc/terms/identifier drugbank_resource:DB00541_DB00872 http://bio2rdf.org/drugbank_resource:DB00541_DB00872 http://purl.org/dc/terms/title DDI between Vincristine and Conivaptan - Conivaptan, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Conivaptan is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00541_DB00872 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00541_DB00872 http://www.w3.org/2000/01/rdf-schema#label DDI between Vincristine and Conivaptan - Conivaptan, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Conivaptan is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB00872] http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#signature.MCwCFEff2VHIbeU- http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#signature.MCwCFEff2VHIbeU- http://purl.org/nanopub/x/hasSignature MCwCFEff2VHIbeU+sOciEHfIun3IAj3BAhQhOaHRjMRdLxGt8QGxobi36RQrzQ== http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#signature.MCwCFEff2VHIbeU- http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://purl.org/dc/terms/created 2018-03-30T11:12:56.769+02:00 http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc#signature.MCwCFEff2VHIbeU- http://bio2rdf.org/drugbank_resource:DB00541_DB00872_nanopub.RAr-R_TnF5NrO4HNjxZFFrC77NQ040-2Vq3nuLlOKfwPc http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234